UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-QSB
QUARTERLY REPORT UNDER SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended December 31, 2007 | Commission File Number 1-13524 |
TIMELINE, INC.
(Exact name of small business issuer as specified in its charter)
Washington | | 91-1590734 |
(State or other jurisdiction of incorporation or organization) | | (IRS Employer Identification No.) |
1700 Seventh Avenue, Ste. 2100
Seattle, WA 98101
(Address of principal executive offices)
(206) 357-8422
(Issuer’s telephone number)
Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date:
Class | | | Outstanding at January 30, 2008 | |
| Common Stock, $.01 Par Value | | | 4,190,798 | |
Transitional Small Business Disclosure Format (check one): Yes o No x
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements
TIMELINE, INC.
CONSOLIDATED BALANCE SHEETS
| | | As of December 31, | | As of, | |
| | | 2007 (Unaudited) | | March 31, 2007 | |
ASSETS | | | | | |
| | | | | | |
| CURRENT ASSETS: | | | | | | | |
| Cash and cash equivalents | | $ | 2,558,184 | | $ | 784,635 | |
| Note receivable | | | 274,403 | | | - | |
| Prepaid expenses and other | | | 2,876 | | | 59,469 | |
Total current assets | | | 2,835,463 | | | 844,104 | |
| | | | | | | | |
| Property and equipment, net of accumulated depreciation of $19,956 and $18,943 | | | 1,663 | | | 2,676 | |
| | | | | | | | |
| Capitalized patents, net of accumulated amortization of $161,328 and $138,310 | | | 255,541 | | | 265,118 | |
| | | | | | | | |
| Long-term notes receivable | | | - | | | 505,609 | |
| | | | | | | | |
| Other assets | | | 2,621 | | | 2,450 | |
| | | | | | | | |
Total assets | | $ | 3,095,288 | | $ | 1,619,957 | |
| | | | | | | | |
LIABILITIES AND SHAREHOLDERS’ EQUITY | | | | | | | |
| | | | | | | | |
| CURRENT LIABILITIES: | | | | | | | |
| Accounts payable | | $ | 22,101 | | $ | 346,436 | |
| Accrued expenses | | | 118,943 | | | 83,655 | |
Total current liabilities | | | 141,044 | | | 430,091 | |
| | | | | | | | |
| Total liabilities | | | 141,044 | | | 430,091 | |
| | | | | | | | |
| SHAREHOLDERS’ EQUITY: | | | | | | | |
| Common stock, $0.01 par value, 20,000,000 shares authorized, 4,190,998 shares issued and outstanding | | | 41,910 | | | 41,910 | |
| Additional paid-in capital | | | 10,584,396 | | | 10,584,396 | |
| Accumulated deficit | | | (7,672,062 | ) | | (9,436,440 | ) |
Total shareholders’ equity | | | 2,954,244 | | | 1,189,866 | |
Total liabilities and shareholders’ equity | | $ | 3,095,288 | | $ | 1,619,957 | |
The accompanying condensed notes are an integral part of these consolidated financial statements.
TIMELINE, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
For the Three Months and Nine Months Ended December 31, 2007 and 2006
(unaudited)
| | | Three Months Ended December 31, | | Nine Months Ended December 31, | |
| | | 2007 | | 2006 | | 2007 | | 2006 | |
| REVENUE: | | | | | | | | | | | | | |
Patent license | | $ | 5,000,000 | | $ | - | | $ | 5,000,000 | | $ | - | |
Consulting and other | | | - | | | - | | | - | | | - | |
Total revenues | | | 5,000,000 | | | - | | | 5,000,000 | | | - | |
| | | | | | | | | | | | | | |
| COST OF REVENUES: | | | | | | | | | | | | | |
Patent license | | | 7,813 | | | 7,386 | | | 23,018 | | | 21,993 | |
Total cost of revenues | | | 7,813 | | | 7,386 | | | 23,018 | | | 21,993 | |
Gross income (loss) | | | 4,992,187 | | | (7,386 | ) | | 4,976,982 | | | (21,993 | ) |
| | | | | | | | | | | | | | |
| OPERATING EXPENSES: | | | | | | | | | | | | | |
General and administrative | | | 132,731 | | | 144,768 | | | 202,303 | | | 303,442 | |
Patents | | | 2,401,636 | | | 103,838 | | | 3,017,312 | | | 183,246 | |
Depreciation | | | 338 | | | 338 | | | 1,013 | | | 1,047 | |
Discount on note receivable | | | - | | | - | | | 40,000 | | | - | |
Total operating expenses | | | 2,534,705 | | | 248,944 | | | 3,260,628 | | | 487,735 | |
Income (loss) from operations | | | 2,457,482 | | | (256,330 | ) | | 1,716,354 | | | (509,728 | ) |
| | | | | | | | | | | | | | |
| OTHER INCOME: | | | | | | | | | | | | | |
Interest income and other | | | 23,688 | | | 24,975 | | | 48,024 | | | 77,972 | |
Total other income | | | 23,688 | | | 24,975 | | | 48,024 | | | 77,972 | |
| | | | | | | | | | | | | | |
| Income (loss) from operations before income taxes | | | 2,481,170 | | | (231,355 | ) | | 1,764,378 | | | (431,756 | ) |
| | | | | | | | | | | | | | |
| Provision for income tax | | | - | | | - | | | - | | | - | |
Net income (loss) | | $ | 2,481,170 | | $ | (231,355 | ) | $ | 1,764,378 | | $ | (431,756 | ) |
| | | | | | | | | | | | | | |
| Basic net income (loss) per share from operations | | $ | 0.59 | | $ | (0.06 | ) | $ | 0.42 | | $ | (0.10 | ) |
| Diluted net income (loss) per share | | $ | 0.59 | | $ | (0.06 | ) | $ | 0.42 | | $ | (0.10 | ) |
| Shares used in calculation of basic and diluted net income (loss) per share | | | 4,190,998 | | | 4,190,998 | | | 4,190,998 | | | 4,190,998 | |
The accompanying condensed notes are an integral part of these interim consolidated financial statements.
TIMELINE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Nine Months Ended December 31, 2007 and 2006
(unaudited)
| | | 2007 | | 2006 | |
| | | | | | |
| CASH FLOWS FROM OPERATING ACTIVITIES: | | | | | | | |
Net income (loss) | | $ | 1,764,378 | | $ | (431,756 | ) |
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | | | | | | | |
Depreciation and amortization | | | 24,032 | | | 23,040 | |
Discount on note receivable | | | 40,000 | | | - | |
Stock-based compensation | | | - | | | 5,950 | |
Changes in operating assets and liabilities: | | | | | | | |
Prepaid expenses and other | | | 56,593 | | | 44,429 | |
Accounts payable | | | (324,335 | ) | | 39,134 | |
Accrued expenses and other | | | 35,288 | | | 37,745 | |
Interest from note receivable | | | (8,795 | ) | | (45,000 | ) |
Other assets | | | (171 | ) | | - | |
Net cash used in operating activities | | | 1,586,990 | | | 326,458 | |
| | | | | | | | |
| CASH FLOWS FROM INVESTING ACTIVITIES: | | | | | | | |
Investment in capitalized software and patents | | | (13,441 | ) | | (10,207 | ) |
Proceeds from note receivable | | | 200,000 | | | - | |
Net cash from (used in) investing activities | | | 186,559 | | | (10,207 | ) |
| | | | | | | | |
| CASH FLOWS FROM FINANCING ACTIVITIES | | | - | | | - | |
| | | | | | | | |
| NET CHANGE IN CASH AND CASH EQUIVALENTS | | | 1,773,549 | | | (336,665 | ) |
| | | | | | | | |
| CASH AND CASH EQUIVALENTS, beginning of period | | | 784,635 | | | 1,158,172 | |
| | | | | | | | |
| CASH AND CASH EQUIVALENTS, end of period | | $ | 2,558,184 | | $ | 821,507 | |
| | | | | | | | |
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | | | | | | | |
Cash paid for interest | | $ | - | | $ | - | |
The accompanying condensed notes are an integral part of these consolidated financial statements.
TIMELINE, INC.
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007
1. THE COMPANY
Organization
The accompanying consolidated financial statements are of Timeline, Inc. and subsidiaries. Timeline, which is headquartered in Seattle, Washington, licenses intellectual property protected by patents granted by the U.S. Patent and Trademark Office and eight other countries.
Operations
We are in the business of licensing our intellectual property which consists of a portfolio of patents granted in nine different countries consisting of the United States of America, Australia, Canada, China, Hong Kong, Israel, Korea, Mexico and Singapore. At December 31, 2007, this line of business had generated approximately $19.8 million in total patent license fees since March 1998. However, patent licensing tends to be very litigious in nature and, as such, revenue generation has been and is expected to continue to be sporadic.
As of December 31, 2007, we had net working capital of approximately $2,694,000 and had an accumulated deficit of approximately $7,672,000 with total shareholders’ equity of approximately $2,954,000. These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, assuming we will continue as a going concern. Our auditors for fiscal year ended March 31, 2007, added an explanatory paragraph to their opinion on our fiscal 2007 financial statements stating that there was substantial doubt about our ability to continue as a going concern. In October 2007, we settled our patent litigation against ProClarity Corporation and we believe that our current cash and cash equivalents, and any net cash provided by operations are sufficient to meet anticipated cash needs for working capital and capital expenditures into fiscal 2009.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Interim Financial Statements
The accompanying consolidated financial statements are unaudited, but in our opinion the financial statements include all adjustments necessary to state fairly the financial information set forth in this report in conformity with accounting principles generally accepted in the United States of America. Operating results for the three months and nine months ended December 31, 2007 are not necessarily indicative of the results that may be expected for the year ending March 31, 2008.
Certain notes and other information have been condensed or omitted from the interim financial statements presented in this Quarterly Report on Form 10-QSB. Accordingly, these financial statements should be read in conjunction with our annual financial statements for the year ended March 31, 2007, as previously reported in our Form 10-KSB.
Use of Estimates
The preparation of financial statements in accordance with generally accepted accounting principles requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities known to exist as of the date the financial statements are published, and the reported amounts of revenues and expenses during the reporting period. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of our financial statements. Accordingly, it is possible that the actual results could differ from these estimates and assumptions that could have a material effect on the reported amounts of our financial position and results of operations.
Basis of Presentation
Our subsidiaries, all wholly-owned, did not generate any revenue or expense for the quarter ended December 31, 2007.
Revenue Recognition
Revenue generated from the licensing of patents is recognized when a patent license agreement is signed, collectibility is probable and the amount of payment is fixed and determinable, consistent with SOP 97-2 and Staff Accounting Bulletin (SAB) No.101, “Revenue Recognition” (SAB 101).
For all licenses, we use a signed agreement as evidence of an arrangement. At the time of each transaction, we assess whether the fee associated with our revenue transactions is fixed and determinable and whether or not collection is reasonably assured. We assess whether the fee is fixed and determinable based on the payment terms associated with the transaction. If a significant portion of a fee is due after our normal payment terms, we account for the fee as not being fixed and determinable. In these cases, we defer revenue and recognize it when it becomes due and payable.
We assess the probability of collection based on a number of factors including the current financial condition of the customer. We do not request collateral from our customers. If it is determined that collection of a fee is not reasonably assured, revenue is deferred until the time collection becomes reasonably assured.
Net Income (Loss) per Common Share
We have adopted Statement of Financial Accounting Standards No. 128, which provides for calculation of “basic” and “diluted” earnings per share. Basic earnings per share includes no dilution and is computed by dividing net income available to common shareholders by the weighted average common shares outstanding for the period. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity. There were 250,000 stock options and 7,500 warrants of common stock equivalents outstanding at December 31, 2007. Basic earnings per share and diluted earnings per share are the same because under the treasury stock method of calculating diluted earnings per share, the options and warrants would be antidilutive.
Stock-Based Compensation
Effective April 1, 2006, we adopted the fair value method of accounting for stock-based compensation as required under SFAS No. 123R and also elected to use the modified prospective method of transition. As a result, an expense of $5,950 was recorded to reflect the unvested portion of previously granted stock options which vested over the first seven months of fiscal 2007. No new options were granted during fiscal 2007 or the first nine months of fiscal 2008 and, while the expense noted above is fully reflected in the statements, no current deferred tax benefit associated with the subject stock options was recorded as we maintain a valuation allowance that fully offsets our deferred tax assets.
Fair Value of Financial Instruments
Our financial instruments as defined by Statement of Financial Accounting Standard No. 107, “Disclosures about Fair Value of Financial Instruments,” include cash, accounts payable and accrued expenses. All instruments are accounted for on a historical cost basis, which, due to the short maturity of these financial instruments, approximates fair value at December 31, 2007 and March 31, 2007.
Impairment of Long-lived Assets
In accordance with Statement of Financial Accounting Standards No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets” (SFAS No. 144), we evaluate long-lived assets, including intangible assets other than goodwill, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable based on estimated undiscounted cash flows attributable to that asset. The amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset. We do not currently believe that any of our long-lived assets are impaired.
3. LITIGATION
On October 15, 2007, we entered into a Confidential Settlement Agreement with Microsoft Corporation and ProClarity Corporation in settlement of our patent infringement lawsuit filed against Microsoft and ProClarity and our breach of contract lawsuit filed against Microsoft. Also on October 15, 2007, in connection with the Settlement Agreement, we entered into a Confidential Patent License Agreement with Microsoft. Under the Settlement Agreement, Microsoft paid us a one-time payment of $5,000,000 as consideration for entering into the Settlement Agreement and the Patent License Agreement. The net proceeds to us from this amount were reduced by payment of our 45% contingent attorneys’ fees and other expenses of the litigation.
From time to time, we may pursue litigation against other third parties to enforce or protect our rights under our patents or our intellectual property rights generally.
Item 2. Management’s Discussion and Analysis or Plan of Operations
This Quarterly Report on Form 10-QSB includes a number of forward-looking statements that reflect our current views with respect to business strategies, future events and financial performance. These forward-looking statements are subject to certain risks and uncertainties, including those discussed below, that could cause actual results to differ materially from historical results or those anticipated, including the risks and uncertainties described below, as well as in our annual report on Form 10-KSB for the year ended March 31, 2007, under the caption “Risk Factors.” When used in this Report, the words "anticipate," "believe," "may," “could,” “should,” ”would,” "will," "expect," “future,” and variations of such words and similar expressions as they relate to our business are intended to identify such forward-looking statements, but are not the exclusive means of identifying such statements. Our actual results, performance or achievements could differ materially from the results expressed in, or implied by, these forward-looking statements. We do not undertake any obligation to revise these forward-looking statements to reflect any future events or circumstances. In addition, the disclosures under the caption "Risk Factors” consist principally of a brief discussion of risks which may affect future results and are thus, in their entirety, forward-looking in nature. To facilitate readers in identifying forward-looking statements in this Report, we have attempted to mark sentences containing such statements with a single asterisk and paragraphs containing only forward-looking statements with double asterisks. However, no assurance can be made all such statements have been identified and marked. Therefore, readers are urged to carefully review and consider the various disclosures made in this report and in our other reports previously filed with the Securities and Exchange Commission (the "SEC"), including our periodic reports on Forms 10-KSB and 10-QSB, and those described from time to time in our press releases and other communications, which attempt to advise interested parties of the risks and factors that may affect our business.
OVERVIEW
Timeline, Inc., headquartered in Seattle, Washington, licenses intellectual property protected by patents granted by the U.S. Patent and Trademark Office and eight other countries. We currently hold seven patents issued by the U.S. Patent and Trademark Office on our technology, for a total of 148 issued claims. We have also been issued patents in Australia, Canada, China, Hong Kong, Israel, Korea, Mexico and Singapore.
Our consolidated financial statements for the quarter and nine months ended December 31, 2007 have been prepared on a going-concern basis, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. Our auditors for fiscal year ended March 31, 2007, added an explanatory paragraph to their opinion on our fiscal 2007 financial statements stating that there was substantial doubt about our ability to continue as a going concern. In October 2007, we settled our lawsuits against ProClarity Corporation and Microsoft Corporation. Under the settlement agreement, Microsoft paid us a one-time license fee of $5,000,000 and we entered into a patent license agreement with Microsoft. The net proceeds to us from this amount were reduced by payment of our 45% contingent attorneys’ fees and other expenses of the litigation. With the net proceeds from this settlement, we believe that our current cash and cash equivalents, and any net cash provided by operations are sufficient to meet anticipated cash needs for working capital and capital expenditures into fiscal 2009.*
With the settlement of our lawsuits against ProClarity Corporation and Microsoft Corporation, we have recently, under the direction of our Board of Directors, undertaken a review of our options for the future, including whether to continue licensing our patents either directly or in conjunction with a joint venture partner, or whether we can reasonably sell the patents outright; most likely to an entity with the finances and wherewithal to aggressively pursue litigation, if necessary, to maximize the commercial value of the patents. Finally, we are also soliciting potential merger partners who may value the public entity and patents. Of course, the benchmarks against which we must compare these alternative strategies, assuming we have options, is simple liquidation or continuing to license the patents directly. All of these efforts at identifying possible options are intended to allow our Board to decide the best approach going forward to maximize return to our shareholders. No definitive decision has been made in this regard as additional research and completion of various discussions with third parties is needed for our Board of Directors’ consideration.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
The discussion and analysis of our financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates including, among others, those affecting revenues and the useful lives of tangible and intangible assets. The discussion below is intended as a brief discussion of some of the judgments and uncertainties that can impact the application of these policies and the specific dollar amounts reported on our financial statements. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form our basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions, or if we made different judgments or utilized different estimates. Our estimates or judgments are based in part on anticipated future events or performance, and as such are forward-looking in nature, and are subject to many risks and uncertainties, including those discussed below and elsewhere in this Report. We do not undertake any obligation to update or revise this discussion to reflect any future events or circumstances.
We have identified the policies below as critical to our business operations and the understanding of our results of operations. The impact and any associated risks related to these policies on our business operations is discussed throughout Management’s Discussion and Analysis or Plan of Operations where such policies affect our reported and expected financial results. For a detailed discussion on the application of these and our other accounting policies, see the Notes to Consolidated Financial Statements.
Revenue Recognition
We recognize revenue when persuasive evidence of an arrangement exists and delivery has occurred, provided the fee is fixed or determinable, and collectibility is probable. For all patent licenses, we use a signed agreement, as evidence of an arrangement. We assess whether the fee is fixed and determinable based on the payment terms associated with the transaction. If a fee is based upon a variable such as a royalty based on units sold, we account for the fee as not being fixed and determinable. In these cases, we defer revenue and recognize it when it becomes due and payable. We assess the probability of collection based on a number of factors, including past transaction history with the licensee and the current financial condition of the licensee. We do not request collateral from our licensees. If we determine that collection of a fee is not reasonably assured, we defer revenue until the time collection becomes reasonably assured.
Capitalized Patents
We capitalize the direct out-of-pocket costs to obtain patents on our technology. Such costs are amortized over the then remaining life of the respective patents, which had an initial life of 20 years. In the case of maintenance fees to renew our registration of a patent in a particular jurisdiction, the fee would then be amortized over the remaining portion of the original 20 year grant.* Should we determine that we will not be able to generate future revenues as a result of a patent, we would need to write off the remaining capitalized value of the patent in the period we determine that the patent is impaired.* At December 31, 2007, such a write-off would reduce our total assets by approximately $256,000. It would have no effect on cash. Costs of defending our patents are expensed as incurred, which, depending on the nature and complexity of the legal defense strategy, could materially impact our results of operations in any given period.*
Impairment of Long-Lived Assets
We assess the impairment of our long-lived assets, including property and equipment and capitalized patents, whenever events or changes in circumstances indicate that the carrying value may not be recoverable based on estimated undiscounted cash flows attributable to that asset. The amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset. Our judgments regarding the existence of impairment indicators are based on legal factors and market conditions. Future events could cause us to conclude that impairment indicators exist and that certain assets are impaired.* Such an adjustment would have no effect on our current cash.*
RESULTS OF OPERATIONS
Results of Operations
Revenue/Gross Loss
| | | Three Months Ended | | | | Nine Months Ended | | | |
| | | 2007 | | 2006 | | Change | | 2007 | | 2006 | | Change | |
| | | | | | | | | | | | | | |
| Patent license revenue | | $ | 5,000,000 | | $ | - | | | N/A | | $ | 5,000,000 | | $ | - | | | N/A | |
| Patent amortization expense | | | | ) | | (7,386 | ) | | 6 | | | (23,018 | ) | | (21,993 | ) | | 5 | |
| Gross income (loss) | | $ | 4,992,187 | | $ | (7,386 | ) | | N/A | | $ | 4,976,982 | | $ | (21,993 | ) | | N/A | |
Our sole source of revenue, other than interest, is from patent license revenue. We received no revenues during the first three quarters of fiscal 2007 and the first two quarters of fiscal 2008. Revenue received in the fiscal quarter ended December 31, 2007 (third quarter of fiscal 2008) was a one-time payment of $5,000,000 from our patent license agreement with Microsoft Corporation.
Patent amortization expenses consist of amortization of capitalized costs of patent acquisition, filing and maintenance. We capitalize the cost of procuring patents, which mainly consists of attorneys’ and filing fees. We also capitalize the expense of maintaining our registration in the various countries in which the patent has been granted. These costs are amortized over the remaining life of the various patents on a straight line basis. The costs associated with litigation or negotiation of patent licenses with third parties is separately accounted for as “patent expenses” under “Operating Expense” below. Patent amortization expenses for the third quarter and nine-month period of fiscal 2008 increased slightly over the comparable periods in fiscal 2007 due to additional patent-related fees incurred during the last twelve months which added to the amortizable base.
Operating Expense
| | | Three Months Ended | | | | Nine Months Ended | | | |
| | | 2007 | | 2006 | | Change | | 2007 | | 2006 | | Change | |
| | | | | | | | | | | | | | |
| General & administrative | | $ | 132,731 | | $ | 144,768 | | | (8 | )% | $ | 202,303 | | $ | 303,442 | | | (33 | )% |
| Patent expense | | | 2,401,636 | | | 103,838 | | | N/A | | | 3,017,312 | | | 183,246 | | | N/A | |
| Depreciation | | | 338 | | | 338 | | | (0 | )% | | 1,013 | | | 1,047 | | | (3 | )% |
| Discount on note receivable | | | - | | | - | | | N/A | | | 40,000 | | | - | | | N/A | |
| Total operating expense | | $ | 2,534,705 | | $ | 248,944 | | | 918 | % | $ | 3,260,628 | | $ | 487,735 | | | 568 | % |
Expenses of operations in all periods reflect costs associated with patent litigation, pursuing licenses of the patents and the costs of maintaining the public entity.
General and administrative expense consists of salaries, legal and accounting fees, rent, insurance and other expenses associated with maintaining the corporate entity. We have attempted to streamline administrative expenses in all categories of general and administrative expense and achieved savings in this regard are reflected in lower costs in the third quarter and nine months of fiscal 2008. We expect our general and administrative expense in future periods to remain relatively constant. *
Patent expense includes the costs of litigation, which in the third quarter of fiscal 2008 mainly consist of attorneys’ fees. We settled our lawsuits with Microsoft and ProClarity after the opening day of trial, on October 15, 2007, and the costs for the third quarter of fiscal 2008 include payment of our 45% contingent attorneys’ fees from our settlement. Additional costs reflected in patent expense include expert witness fees, travel and reporting costs associated with depositions, and document production costs. Due to the fact litigation activity increased during fiscal 2008 as we approached trial in October, expenses related to the patents increased dramatically over those experienced in fiscal 2007.
Patent expense in future quarters will depend in large part on whether we institute additional litigation.* While that is not our preferred approach, recent decisions in the U.S. Supreme Court and the Federal Circuit Courts make it very difficult to even discuss patent licensing with potential infringers prior to filing a lawsuit. These decisions likely mean the cost of licensing patents will increase dramatically industry wide and the federal court system will become increasingly jammed with such litigation.*
Depreciation expense decreased slightly in the nine months ended December 31, 2007 as compared to 2006.
Other Income and Expense
Other income and expense generated net income of approximately $24,000 in the third quarter and $48,000 in the first nine months of fiscal 2008 and consisted entirely of interest income. This compared to income of approximately $25,000 in the third quarter and $78,000 in the first nine months of fiscal 2007. The decrease was due to lower cash balances in our interest-bearing accounts through the majority of the nine months of fiscal 2008.
Income Tax
No income tax expense was recorded in the comparable three-month and nine-month periods of either fiscal 2008 or fiscal 2007. All income or loss is offset by appropriate adjustments to the valuation allowance of our net operating loss carry-forwards.
LIQUIDITY AND CAPITAL RESOURCES
As of December 31, 2007, we had net working capital of approximately $2,694,000. Additionally, as of December 31, 2007, our cash and cash equivalents were approximately $2,558,000 compared to cash and cash equivalents of approximately $785,000 as of March 31, 2007. This increase was due to patent license revenue generated during the quarter.
At December 31, 2007, we held one note receivable from Global Software, Inc. in principal amount totaling $260,000 from the sale of our software operations to them during fiscal 2006. This note receivable plus accrued and unpaid interest is payable on August 31, 2008. The promissory note bears interest at a rate of 6% per annum, and is a general unsecured obligation of Global. The note is subject to set off in the event of indemnification claims or other claims by Global against us under the Asset Purchase Agreement. As of December 31, 2007, Global had not made any indemnification or other set-off claims against us.
We had no accounts receivable at December 31, 2007 or March 31, 2007.
Total liabilities were approximately $141,000 at December 31, 2007 compared to approximately $430,000 at March 31, 2007. The decrease in total liabilities is attributable to decreases in accounts payable and accrued expenses.
Risk Factors
Please see the discussion under “Risk Factors” contained in our Annual Report on Form 10-KSB for the fiscal year ended March 31, 2007. In addition, our operating results may fluctuate due to a number of factors, including, but not limited to, the following factors:
| | · | our patent licensing strategies regarding when and the number of potential infringers we approach, |
| | · | our ability to pursue and successfully negotiate further patent licenses and generate patent revenues, |
| | · | challenges to the validity of our patents, |
| | · | costs of litigation associated with our patent enforcement, and |
| | · | the cost of maintaining our public status. |
These factors are difficult for us to forecast, and can materially adversely affect our business and operating results for one quarter or a series of quarters.**
Item 3 Controls and Procedure
(a) Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in our filings under the Securities Exchange Act of 1934 is (a) recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and (b) accumulated and communicated to management, including our Chief Executive Officer/Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Our Chief Executive Officer/Chief Financial Officer has evaluated our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-QSB and has determined that such disclosure controls and procedures are effective.
(b) Changes in Internal Controls
During the most recent fiscal quarter, there have been no material changes in our internal controls over financial reporting or in other factors that have materially affected, or are reasonably likely to materially affect our internal controls over financial reporting.
PART II. – OTHER INFORMATION
| Item 6. | | Exhibits |
| | | |
| Exhibits: | | |
| | | |
| 31.1 | | Certification of Charles R. Osenbaugh, President, Chief Executive Officer and Chief Financial Officer of Timeline, Inc. pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| | | |
| 32.1 | | Certification of Charles R. Osenbaugh, President, Chief Executive Officer and Chief Financial Officer of Timeline, Inc. pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
SIGNATURE
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | Timeline, Inc. |
| | (Registrant) |
| | |
| Date: February 8, 2008 | By: | /s/ Charles R. Osenbaugh |
| | Charles R. Osenbaugh |
| | President/Chief Executive Officer/Chief Financial Officer |
| | |
| | Signed on behalf of registrant and as principal financial officer. |
